Literature DB >> 480621

Cytotoxic-induced ovarian failure in Hodgkin's disease. II. Effects on sexual function.

R M Chapman, S B Sutcliffe, J S Malpas.   

Abstract

Chemotheraphy for Hodgkin's disease produces ovarian failure in young women. The consequences of this are emotional distress, sexual dysfunction, and the disruption of families and friendships. These previously unappreciated side effects of cytotoxic therapy had developed in 25 of 41 patients, among whom we conducted a retrospective study.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 480621

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

Review 1.  Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014.

Authors:  Diana D Jeffery; Lisa Barbera; Barbara L Andersen; Amy K Siston; Anuja Jhingran; Shirley R Baron; Jennifer Barsky Reese; Deborah J Coady; Jeanne Carter; Kathryn E Flynn
Journal:  J Psychosoc Oncol       Date:  2015

2.  Hodgkin's disease in adults: the challenge.

Authors:  T A Lister
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

3.  Vaginal occlusion induced by cancer therapy.

Authors:  S C Kaste; S A Gronemeyer; D Muram
Journal:  Pediatr Radiol       Date:  1993

4.  Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy.

Authors:  J H Waxman; Y A Terry; P F Wrigley; J S Malpas; L H Rees; G M Besser; T A Lister
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-04

5.  Do male esophageal cancer patients have impaired sexual function after esophagectomy? A self-reported outcomes study.

Authors:  Xun Cao; Jiu-Di Zhong; Tian-Zhen Yang; Yu-Chuan Jiang; Zhe-Sheng Wen
Journal:  Qual Life Res       Date:  2017-08-01       Impact factor: 4.147

6.  Fertility in young men and women after treatment for lymphoma: a study of a population.

Authors:  D J King; M A Ratcliffe; A A Dawson; B Bennett; J E Macgregor; A I Klopper
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

7.  Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.

Authors:  A M Oza; T S Ganesan; M Dorreen; P W Johnson; J Waxman; W Gregory; J Lim; J Wright; L Dadiotis; V Barbounis
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

8.  Protection of rat spermatogenic epithelium from damage induced by procarbazine chemotherapy.

Authors:  L M Glode; J M Shannon; N Malik; T Nett
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.